Joel Greenblatt fit · Magic Formula — high ROIC + cheap EV/EBIT
Is Esperion Therapeutics, Inc. (ESPR) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
59/100
CMixed signals
2/5 criteria passed
Joel Greenblatt's Criteria, Applied to ESPR
EBIT/EV yield ≥ 10%
key0.9%
ROIC ≥ 25%
key26.9%
EV/EBIT ≤ 12
113.4x
Gross margin ≥ 30%
53.5%
How ESPR Scores on Other Strategies
Live Financial Snapshot
Market cap
$626.17M
P/E (TTM)
-
ROIC (TTM)
26.87%
Gross margin
53.54%
Frequently Asked Questions
What is ESPR's Joel Greenblatt fit score?
ESPR scores 59/100 on our Joel Greenblatt fit engine — grade C. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own ESPR?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ESPR.
How often is this score updated?
ESPR's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends ESPR.